Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00003809 Head and Neck C...
cetuximab
cisplatin
18 Years - 120 Years Eastern Cooperative Oncology Group View Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00033449 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
gefitinib
radiation thera...
cisplatin
laboratory biom...
18 Years - National Cancer Institute (NCI) View Biomarkers in Patients With Head and Neck Cancer NCT01466257 Head and Neck C...
cetuximab
cisplatin
DNA analysis
gene expression...
mutation analys...
laboratory biom...
18 Years - 120 Years Eastern Cooperative Oncology Group View Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors NCT00006036 Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 Years Canadian Cancer Trials Group View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer NCT00004917 Anemia
Head and Neck C...
epoetin alfa
cisplatin
radiation thera...
18 Years - Radiation Therapy Oncology Group View Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00281840 Head and Neck C...
bevacizumab
docetaxel
conventional su...
radiation thera...
18 Years - Case Comprehensive Cancer Center View Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck NCT00084318 Head and Neck C...
cetuximab
cisplatin
docetaxel
radiation thera...
18 Years - Radiation Therapy Oncology Group View PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery NCT00276523 Head and Neck C...
PEG-interferon ...
Conventional su...
Neoadjuvant the...
18 Years - M.D. Anderson Cancer Center View Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx NCT00899340 Head and Neck C...
gene expression...
microarray anal...
protein express...
immunohistochem...
laboratory biom...
- Vanderbilt-Ingram Cancer Center View Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer NCT02177838 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer NCT00002654 Head and Neck C...
chemotherapy
cisplatin
low-LET cobalt-...
low-LET electro...
low-LET photon ...
20 Years - 75 Years Swiss Group for Clinical Cancer Research View Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer NCT00003888 Head and Neck C...
cisplatin
docetaxel
fluorouracil
radiation thera...
18 Years - 70 Years European Organisation for Research and Treatment of Cancer - EORTC View Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00006107 Head and Neck C...
Taxotere
Surgery
radiation thera...
18 Years - Dana-Farber Cancer Institute View Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer NCT00023959 Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI) View 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx NCT00757549 Head and Neck C...
cetuximab
cisplatin
TdT-mediated dU...
3'-deoxy-3'-[18...
immunohistochem...
laboratory biom...
fludeoxyglucose...
radiation thera...
18 Years - 120 Years Mayo Clinic View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer NCT00068237 Head and Neck C...
Radiation Toxic...
Xerostomia
salivary gland ...
Post-operative ...
18 Years - Radiation Therapy Oncology Group View Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer NCT00963326 Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI) View Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer NCT00720083 Head and Neck C...
cisplatin
vandetanib
radiation thera...
18 Years - Radiation Therapy Oncology Group View Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00114153 Head and Neck C...
capecitabine
carboplatin
conventional su...
radiation thera...
18 Years - National Cancer Institute (NCI) View Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer NCT00005035 Head and Neck C...
oxaliplatin
18 Years - National Cancer Institute (NCI) View Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer NCT00014118 Head and Neck C...
carboplatin
paclitaxel
conventional su...
radiation thera...
18 Years - 120 Years Eastern Cooperative Oncology Group View Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer NCT00006360 Head and Neck C...
Radiation Toxic...
radioprotection
radiation thera...
18 Years - 120 Years Radiation Therapy Oncology Group View DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer NCT00898664 Head and Neck C...
cytogenetic ana...
gene expression...
mutation analys...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Vanderbilt-Ingram Cancer Center View Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00352118 Head and Neck C...
filgrastim
pegfilgrastim
cisplatin
docetaxel
fluorouracil
conventional su...
radiation thera...
18 Years - Masonic Cancer Center, University of Minnesota View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx NCT00899340 Head and Neck C...
gene expression...
microarray anal...
protein express...
immunohistochem...
laboratory biom...
- Vanderbilt-Ingram Cancer Center View Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases NCT00062348 Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer NCT00963326 Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI) View Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx NCT00004227 Head and Neck C...
cetuximab
conventional su...
radiation thera...
18 Years - University of Alabama at Birmingham View Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00003328 Head and Neck C...
porfiromycin
radiation thera...
18 Years - National Cancer Institute (NCI) View SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue NCT00002735 Head and Neck C...
Induction chemo...
cisplatin
fluorouracil
low-LET cobalt-...
18 Years - 120 Years SWOG Cancer Research Network View Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck NCT00063895 Recurrent Non-s...
Recurrent Ovari...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IIIA Non-...
Stage IIIA Ovar...
Stage IIIB Non-...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
erlotinib hydro...
pharmacological...
pharmacogenomic...
laboratory biom...
18 Years - National Cancer Institute (NCI) View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery NCT00041171 Adult Solid Tum...
Breast Cancer
Head and Neck C...
Kidney and Urin...
Male Reproducti...
Thorax and Resp...
Hypericum perfo...
docetaxel
placebo
18 Years - 120 Years Alliance for Clinical Trials in Oncology View Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00410826 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
erlotinib hydro...
cisplatin
3-dimensional c...
intensity-modul...
quality-of-life...
18 Years - University of Washington View AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer NCT00415298 Head and Neck C...
DACH polymer pl...
oxaliplatin
gene expression...
immunohistochem...
pharmacological...
biopsy
18 Years - National Cancer Institute (NCI) View Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer NCT00897793 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center View Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00721513 Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 Years Wake Forest University Health Sciences View Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer NCT01953952 Stage III Squam...
Stage IVA Squam...
Tongue Cancer
therapeutic con...
intensity-modul...
cisplatin
quality-of-life...
laboratory biom...
18 Years - Radiation Therapy Oncology Group View Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer NCT00851877 Head and Neck C...
Cetuximab
Cisplatin
Nab-Paclitaxel
intensity-modul...
18 Years - 120 Years University of Texas Southwestern Medical Center View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View Docetaxel in Treating Patients With Solid Tumors NCT00003565 Bladder Cancer
Breast Cancer
Head and Neck C...
Lung Cancer
Unspecified Adu...
docetaxel
18 Years - Alliance for Clinical Trials in Oncology View Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer NCT00003251 Drug/Agent Toxi...
Head and Neck C...
Radiation Toxic...
amifostine trih...
cisplatin
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI) View Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck NCT00079053 Head and Neck C...
erlotinib hydro...
adjuvant therap...
18 Years - 120 Years Canadian Cancer Trials Group View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy NCT01728480 Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute View Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer NCT02177838 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer NCT00084435 Head and Neck C...
cisplatin
docetaxel
radiation thera...
18 Years - SWOG Cancer Research Network View Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy NCT02123511 Mucositis
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Lympho...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Lymph...
Stage IVA Mucoe...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Lymph...
Stage IVB Mucoe...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Lymph...
Stage IVC Mucoe...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
acetylcysteine
placebo
quality-of-life...
questionnaire a...
18 Years - Mayo Clinic View Radiation Therapy in Treating Patients With Head and Neck Cancer NCT00021125 Head and Neck C...
Non-melanomatou...
adjuvant therap...
radiation thera...
- National Cancer Institute (NCI) View Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy NCT00898430 Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00720304 Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center View Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer NCT00899821 Head and Neck C...
aldesleukin
recombinant int...
sargramostim
immunologic tec...
biopsy
20 Years - 80 Years NYU Langone Health View Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer NCT01084083 Head and Neck C...
Precancerous Co...
cetuximab
intensity-modul...
Paclitaxel
Cisplatin
18 Years - Eastern Cooperative Oncology Group View Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer NCT00006033 Head and Neck C...
gene therapy
interleukin-2 g...
methotrexate
18 Years - National Cancer Institute (NCI) View Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer NCT00003582 Carcinoma of Un...
Head and Neck C...
amifostine trih...
cisplatin
fluorouracil
paclitaxel
quality-of-life...
radiation thera...
18 Years - 120 Years University of Miami View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx NCT00004234 Head and Neck C...
Oral Complicati...
management of t...
radiation thera...
16 Years - 120 Years Canadian Cancer Trials Group View Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors NCT01504932 Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Tongue Cancer
BRB Lozenge
Survey Administ...
Laboratory Biom...
pharmacological...
21 Years - Ohio State University Comprehensive Cancer Center View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx NCT00004234 Head and Neck C...
Oral Complicati...
management of t...
radiation thera...
16 Years - 120 Years Canadian Cancer Trials Group View Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer NCT00665392 Head and Neck C...
cisplatin
docetaxel
fluorouracil
Cetuximab
18 Years - 75 Years GERCOR - Multidisciplinary Oncology Cooperative Group View Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00281840 Head and Neck C...
bevacizumab
docetaxel
conventional su...
radiation thera...
18 Years - Case Comprehensive Cancer Center View Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck NCT00083057 Head and Neck C...
gefitinib
paclitaxel
radiation thera...
18 Years - National Institutes of Health Clinical Center (CC) View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00049283 Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat NCT00017173 Head and Neck C...
Ad5CMV-p53 gene
cisplatin
conventional su...
radiation thera...
18 Years - SWOG Cancer Research Network View Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia NCT00081029 Head and Neck C...
Radiation Toxic...
Xerostomia
management of t...
radiation thera...
- National Cancer Institute (NCI) View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract NCT00765440 Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 Years Centre Antoine Lacassagne View Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors NCT00006036 Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 Years Canadian Cancer Trials Group View Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00721513 Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 Years Wake Forest University Health Sciences View Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery NCT00002670 Head and Neck C...
chemotherapy
cisplatin
low-LET cobalt-...
low-LET electro...
low-LET photon ...
18 Years - Radiation Therapy Oncology Group View Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer NCT00566540 Head and Neck C...
Cisplatin
Paclitaxel
Intensity-Modul...
Triple endoscop...
18 Years - Ohio State University Comprehensive Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00049283 Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer NCT01155609 Mucositis
Oral Complicati...
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
quality-of-life...
management of t...
L-lysine
18 Years - University of Washington View